BMT CTN Protocol 0903

Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodyplastic Syndromes in HIV-infected Patients

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair: Joseph Alvarnas, MD jalvarnas@coh.org

            Protocol Co-Chair: Richard Ambinder, MD (410-955-8839) ambinri@jhmi.edu

            Protocol Officer: Willis Navarro wnavarro@atarabio.com

            Protocol Coordinator: Samantha Wilkins (301-251-1161) swilkins@emmes.com

            Medical Monitor: Tammy Kindwall-Keller, MD tlk5de@hscmail.mcc.virginia.edu

        

           

The BMT CTN 0903 study closed to new patient accrual on December 3, 2015.